Syros Pharmaceuticals Past Performance
How has Syros Pharmaceuticals performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SYRS is currently unprofitable.
Growing Profit Margin: SYRS is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SYRS is unprofitable, and losses have increased over the past 5 years at a rate of 14.3% per year.
Accelerating Growth: Unable to compare SYRS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SYRS is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (53%).
Return on Equity
High ROE: SYRS has a negative Return on Equity (-88.02%), as it is currently unprofitable.